NEW YORK (BUSINESS WIRE) #A Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”) (NASDAQ: INFI) in the United States District Court for the District of Massachuset.
NEW YORK (BUSINESS WIRE) #A Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fate Therapeutics, Inc. (NASDAQ: FATE) on behalf of long-term stockholders following a class action complaint that was filed against Fate on January 20, 2023 with.
NEW YORK (BUSINESS WIRE) #A Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) in the United States District Court for the Southern District of New Y.
NEW YORK (BUSINESS WIRE) #A Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Twist Bioscience Corp (“Twist” or the “Company”) (NASDAQ: TWST) in the United States District Court of Northern California on behalf of all per.